Historical Stock Price
ETFs Holding KDNY »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/11/2022 $20.51 $20.94 $19.76 $19.99 574.70K
08/12/2022 $20.22 $21.05 $19.99 $20.64 427.00K
08/15/2022 $20.52 $21.05 $20.31 $21.01 562.70K
08/16/2022 $21.21 $22.93 $20.46 $22.44 2.30M
08/17/2022 $22.14 $22.35 $21.35 $21.61 444.40K
Chinook Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing precision medicines for kidney diseases. Co.'s pipeline is focused on kidney diseases with clinical pathways. Co.'s lead clinical program is atrasentan, an endothelin A receptor antagonist. Co.'s second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in development for patients with IgA nephropathy. Co. developing CHK-336 for the treatment of primary hyperoxaluria as well as secondary hyperoxaluria and idiopathic kidney stone formation. Co. is also conducting research programs in several other rare, severe chronic kidney diseases.
KDNY historical stock prices picture
Chinook Therapeutics (KDNY) has the following price history information. Looking back at KDNY historical stock prices for the last five trading days, on August 11, 2022, KDNY opened at $20.51, traded as high as $20.94 and as low as $19.76, and closed at $19.99. Trading volume was a total of 574.70K shares. On August 12, 2022, KDNY opened at $20.22, traded as high as $21.05 and as low as $19.99, and closed at $20.64. Trading volume was a total of 427.00K shares. On August 15, 2022, KDNY opened at $20.52, traded as high as $21.05 and as low as $20.31, and closed at $21.01. Trading volume was a total of 562.70K shares. On August 16, 2022, KDNY opened at $21.21, traded as high as $22.93 and as low as $20.46, and closed at $22.44. Trading volume was a total of 2.30M shares. On August 17, 2022, KDNY opened at $22.14, traded as high as $22.35 and as low as $21.35, and closed at $21.61. Trading volume was a total of 444.40K shares.

KDNY Historical Stock Prices By Date:

KDNY historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Chinook Therapeutics shares, starting with a $10,000 purchase of KDNY, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/16/2015
End date: 08/17/2022
Start price/share: $39.40
End price/share: $21.61
Dividends collected/share: $0.00
Total return: -45.15%
Average Annual Total Return: -7.85%
Starting investment: $10,000.00
Ending investment: $5,486.66
Years: 7.34
Date Close
08/11/2022$19.99
08/12/2022$20.64
08/15/2022$21.01
08/16/2022$22.44
08/17/2022$21.61
KDNY is categorized under the Healthcare sector; below are some other companies in the same sector:

KEQU Historical Stock Prices
KERX Historical Stock Prices
KIDS Historical Stock Prices
KIN Historical Stock Prices
KIPS Historical Stock Prices
KITE Historical Stock Prices
KLDO Historical Stock Prices
KMPH Historical Stock Prices
KND Historical Stock Prices
KNTE Historical Stock Prices

Also explore: KDNY shares outstanding history

Email EnvelopeFree KDNY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

KDNY Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.